HCA Healthcare (NYSE:HCA) Shares Up 4.1% - Time to Buy?

HCA Healthcare logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • HCA shares rose 4.1% in Friday midday trading to about $479.18, on volume 52% below the average session volume.
  • Analysts give the stock a “Moderate Buy” consensus, with an average price target of $482.30; 16 rate it Buy, seven Hold, and one Sell.
  • In its latest quarter, HCA beat estimates with EPS of $7.22 and revenue of $19.85 billion, up 3.6% year over year. It also announced a quarterly dividend of $0.78 per share.
  • Five stocks to consider instead of HCA Healthcare.

HCA Healthcare, Inc. (NYSE:HCA - Get Free Report)'s stock price was up 4.1% during mid-day trading on Friday. The stock traded as high as $479.77 and last traded at $479.1820. Approximately 640,473 shares traded hands during mid-day trading, a decline of 52% from the average session volume of 1,344,104 shares. The stock had previously closed at $460.33.

Wall Street Analyst Weigh In

HCA has been the subject of a number of research reports. Royal Bank Of Canada lifted their target price on HCA Healthcare from $496.00 to $521.00 and gave the stock an "outperform" rating in a report on Friday, October 30th. Mizuho set a $495.00 price target on shares of HCA Healthcare in a research report on Wednesday, October 28th. JPMorgan Chase & Co. lifted their price objective on shares of HCA Healthcare from $425.00 to $475.00 and gave the company a "neutral" rating in a research note on Wednesday. Cantor Fitzgerald reiterated an "overweight" rating on shares of HCA Healthcare in a research note on Friday, October 2nd. Finally, Barclays boosted their target price on shares of HCA Healthcare from $387.00 to $401.00 and gave the company an "equal weight" rating in a research report on Thursday, October 29th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $482.30.

Get Our Latest Stock Report on HCA Healthcare

HCA Healthcare Stock Up 3.5%

The firm has a 50-day moving average of $458.75 and a two-hundred day moving average of $445.87. The company has a market capitalization of $99.57 billion, a PE ratio of 15.78, a PEG ratio of 1.59 and a beta of 1.11.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, topping analysts' consensus estimates of $6.65 by $0.57. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. The business had revenue of $19.85 billion for the quarter, compared to analysts' expectations of $19.33 billion. During the same quarter last year, the company earned $6.96 EPS. The business's revenue was up 3.6% on a year-over-year basis. Equities analysts predict that HCA Healthcare, Inc. will post 30.14 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 29th. Stockholders of record on Tuesday, December 15th will be paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, December 15th. HCA Healthcare's dividend payout ratio is presently 10.34%.

Insider Activity

In related news, SVP Erica Rossitto sold 3,500 shares of the company's stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $505.81, for a total value of $1,770,335.00. Following the completion of the transaction, the senior vice president owned 13,426 shares of the company's stock, valued at approximately $6,791,005.06. This represents a 20.68% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Jon Foster sold 21,713 shares of the stock in a transaction that occurred on Friday, November 6th. The stock was sold at an average price of $494.95, for a total value of $10,746,849.35. Following the transaction, the chief operating officer owned 10,000 shares in the company, valued at $4,949,500. This represents a 68.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 36,413 shares of company stock worth $18,251,464 in the last ninety days. Company insiders own 1.50% of the company's stock.

Hedge Funds Weigh In On HCA Healthcare

A number of large investors have recently added to or reduced their stakes in the stock. BlackRock Inc. purchased a new stake in shares of HCA Healthcare during the second quarter worth about $5,069,974,000. Legal & General Group Plc acquired a new stake in HCA Healthcare in the 2nd quarter worth about $410,992,000. Jupiter Topco LLC purchased a new stake in HCA Healthcare during the 2nd quarter worth approximately $371,138,000. Wellington Management Group LLP raised its holdings in shares of HCA Healthcare by 20.5% during the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company's stock valued at $1,835,397,000 after acquiring an additional 799,761 shares during the last quarter. Finally, Bank of America Corp DE purchased a new position in shares of HCA Healthcare in the second quarter valued at approximately $238,457,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

About HCA Healthcare

(Get Free Report)

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in HCA Healthcare Right Now?

Before you consider HCA Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.

While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines